Display options
Cite
Killig M, Glatzer T, Romagnani C. Recognition strategies of group 3 innate lymphoid cells. Front Immunol. 2014;5:142doi: 10.3389/fimmu.2014.00142.
Killig, M., Glatzer, T., & Romagnani, C. (2014). Recognition strategies of group 3 innate lymphoid cells. Frontiers in immunology, 5142. https://doi.org/10.3389/fimmu.2014.00142
Killig, Monica, et al. "Recognition strategies of group 3 innate lymphoid cells." Frontiers in immunology vol. 5 (2014): 142. doi: https://doi.org/10.3389/fimmu.2014.00142
Killig M, Glatzer T, Romagnani C. Recognition strategies of group 3 innate lymphoid cells. Front Immunol. 2014 Apr 01;5:142. doi: 10.3389/fimmu.2014.00142. eCollection 2014. PMID: 24744763; PMCID: PMC3978353.
Copy Download .nbib Format: NLM
Share it on

Front Immunol. 2014 Apr 01;5:142. doi: 10.3389/fimmu.2014.00142. eCollection 2014.

Recognition strategies of group 3 innate lymphoid cells.

Frontiers in immunology

Monica Killig, Timor Glatzer, Chiara Romagnani

Affiliations

  1. Innate Immunity, Leibniz Institute, German Rheumatism Research Center , Berlin , Germany.

PMID: 24744763 PMCID: PMC3978353 DOI: 10.3389/fimmu.2014.00142

Abstract

During the early phase of an inflammatory response, innate cells can use different strategies to sense environmental danger. These include the direct interaction of specific activating receptors with pathogen-encoded/danger molecules or the engagement of cytokine receptors by pro-inflammatory mediators produced by antigen presenting cells in the course of the infection. These general recognition strategies, which have been extensively described for innate myeloid cells, are shared by innate lymphoid cells (ILC), such as Natural Killer (NK) cells. The family of ILC has recently expanded with the discovery of group 2 (ILC2) and group 3 ILC (ILC3), which play an important role in the defense against extracellular pathogens. Although ILC3 and NK cells share some phenotypic characteristics, the recognition strategies employed by the various ILC3 subsets have been only partially characterized. In this review, we will describe and comparatively discuss how ILC3 sense environmental cues and how the triggering of different receptors may regulate their functional behavior during an immune response.

Keywords: AHR; ILC3; NCR; NKp44; RORĪ³t; innate lymphoid cells

References

  1. J Exp Med. 2009 Jul 6;206(7):1465-72 - PubMed
  2. Nature. 2008 Nov 27;456(7221):507-10 - PubMed
  3. Nat Med. 2008 Mar;14(3):275-81 - PubMed
  4. Immunity. 2010 Nov 24;33(5):752-64 - PubMed
  5. Nature. 2013 Feb 14;494(7436):261-5 - PubMed
  6. Annu Rev Immunol. 2001;19:197-223 - PubMed
  7. Science. 2010 Oct 29;330(6004):665-9 - PubMed
  8. Immunity. 2009 Aug 21;31(2):321-30 - PubMed
  9. Immunity. 2007 Dec;27(6):965-74 - PubMed
  10. Trends Immunol. 2013 Apr;34(4):182-91 - PubMed
  11. J Immunol. 2001 Jun 1;166(11):6593-601 - PubMed
  12. Annu Rev Pharmacol Toxicol. 2000;40:519-61 - PubMed
  13. Immunity. 2008 Dec 19;29(6):947-57 - PubMed
  14. Immunity. 2010 Nov 24;33(5):736-51 - PubMed
  15. J Immunol. 2009 Nov 15;183(10):6579-87 - PubMed
  16. Eur J Immunol. 1992 Feb;22(2):329-34 - PubMed
  17. Nature. 2010 Apr 29;464(7293):1371-5 - PubMed
  18. J Exp Med. 2001 Mar 5;193(5):621-30 - PubMed
  19. Nat Med. 2008 Mar;14(3):282-9 - PubMed
  20. Hepatology. 2004 May;39(5):1332-42 - PubMed
  21. Immunity. 2012 Dec 14;37(6):1061-75 - PubMed
  22. Immunity. 2007 Oct;27(4):647-59 - PubMed
  23. Ann Rheum Dis. 2007 Nov;66 Suppl 3:iii91-5 - PubMed
  24. Nat Immunol. 2011 Sep 11;12(11):1055-62 - PubMed
  25. Immunity. 2012 Jan 27;36(1):92-104 - PubMed
  26. J Exp Med. 1999 Mar 1;189(5):787-96 - PubMed
  27. J Exp Med. 2009 Jul 6;206(7):1495-503 - PubMed
  28. J Clin Invest. 2008 Feb;118(2):534-44 - PubMed
  29. Blood. 2013 Oct 24;122(17):2935-42 - PubMed
  30. Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10132-7 - PubMed
  31. Immunity. 2012 Oct 19;37(4):649-59 - PubMed
  32. Immunology. 2009 Jul;127(3):299-311 - PubMed
  33. J Immunol. 2006 Nov 15;177(10):6824-32 - PubMed
  34. Front Immunol. 2013 Dec 30;4:499 - PubMed
  35. Immunity. 2013 Jun 27;38(6):1223-35 - PubMed
  36. Science. 2000 Jun 30;288(5475):2369-73 - PubMed
  37. Infect Immun. 2008 Apr;76(4):1719-27 - PubMed
  38. Front Immunol. 2012 Feb 29;3:24 - PubMed
  39. Immunity. 2011 Jan 28;34(1):122-34 - PubMed
  40. Science. 2012 Jun 8;336(6086):1321-5 - PubMed
  41. Immunol Rev. 2008 Dec;226:103-11 - PubMed
  42. Nat Immunol. 2013 Apr;14(4):389-95 - PubMed
  43. J Exp Med. 2010 Feb 15;207(2):281-90 - PubMed
  44. Cell Immunol. 2013 Sep-Oct;285(1-2):6-9 - PubMed
  45. J Immunol. 2013 Jan 15;190(2):521-5 - PubMed
  46. Semin Immunol. 2012 Jun;24(3):165-74 - PubMed
  47. Annu Rev Immunol. 2005;23:225-74 - PubMed
  48. Nat Immunol. 2009 Jan;10(1):75-82 - PubMed
  49. Curr Opin Immunol. 2012 Aug;24(4):449-58 - PubMed
  50. J Rheumatol. 2011 Oct;38(10):2112-8 - PubMed
  51. Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G827-38 - PubMed
  52. Nat Rev Immunol. 2009 Apr;9(4):229-34 - PubMed
  53. Immunity. 2008 Aug 15;29(2):261-71 - PubMed
  54. Nat Immunol. 2011 Nov 20;13(2):144-51 - PubMed
  55. PLoS One. 2007 Dec 19;2(12):e1339 - PubMed
  56. J Exp Med. 2003 May 5;197(9):1191-8 - PubMed
  57. Immunity. 2003 Sep;19(3):311-5 - PubMed
  58. Inflamm Bowel Dis. 2006 Jan;12(1):1-8 - PubMed
  59. Semin Immunol. 2013 Dec 15;25(6):389-93 - PubMed
  60. J Immunol. 2011 Dec 1;187(11):5693-702 - PubMed
  61. Annu Rev Immunol. 2012;30:647-75 - PubMed
  62. EMBO J. 2011 Jun 17;30(14):2934-47 - PubMed
  63. J Exp Med. 2011 Jun 6;208(6):1127-33 - PubMed
  64. Cell. 2006 Feb 24;124(4):783-801 - PubMed
  65. Science. 2011 Dec 16;334(6062):1561-5 - PubMed
  66. Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10961-6 - PubMed
  67. Immunity. 2004 Aug;21(2):241-54 - PubMed
  68. J Exp Med. 2009 Jan 16;206(1):35-41 - PubMed
  69. J Exp Med. 1998 Jun 15;187(12):2065-72 - PubMed
  70. Nature. 2009 Feb 5;457(7230):722-5 - PubMed
  71. J Exp Med. 2006 Oct 2;203(10):2271-9 - PubMed
  72. Immunol Rev. 2003 Oct;195:81-90 - PubMed
  73. J Immunol. 2002 Jan 1;168(1):57-64 - PubMed
  74. Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10116-21 - PubMed
  75. Eur J Immunol. 2005 Jan;35(1):98-107 - PubMed
  76. Immunity. 2013 Aug 22;39(2):372-85 - PubMed
  77. Immunol Rev. 2012 Jan;245(1):177-88 - PubMed
  78. Curr Protoc Immunol. 2010 Aug;Chapter 11:Unit 11.9B - PubMed
  79. Annu Rev Physiol. 2010;72:625-45 - PubMed
  80. Front Immunol. 2012 Apr 09;3:72 - PubMed
  81. Nat Immunol. 2004 Jan;5(1):64-73 - PubMed
  82. Hepatology. 2011 Jul;54(1):252-61 - PubMed
  83. Biol Pharm Bull. 2012;35(4):594-600 - PubMed
  84. Nat Immunol. 2008 May;9(5):503-10 - PubMed
  85. Immunity. 2008 Dec 19;29(6):958-70 - PubMed
  86. Immunity. 2013 Aug 22;39(2):386-99 - PubMed
  87. Int Immunol. 1999 May;11(5):643-55 - PubMed
  88. Nat Immunol. 2009 Jan;10(1):83-91 - PubMed
  89. Immunity. 1997 Oct;7(4):493-504 - PubMed
  90. Nat Immunol. 2011 May;12(5):383-90 - PubMed
  91. Nat Rev Immunol. 2010 Sep;10(9):664-74 - PubMed
  92. J Exp Med. 2012 Aug 27;209(9):1595-609 - PubMed
  93. Eur J Immunol. 2001 Sep;31(9):2680-9 - PubMed
  94. Nat Immunol. 2011 Apr;12(4):320-6 - PubMed
  95. J Exp Med. 2012 Dec 17;209(13):2331-8 - PubMed
  96. Nat Immunol. 2009 Jan;10(1):66-74 - PubMed
  97. J Exp Med. 1996 Oct 1;184(4):1449-59 - PubMed

Publication Types